Schedule I (Notes)

12 Months Ended

Dec. 31, 2018

Condensed Statement of Income Captions [Line Items]

Condensed Financial Information of Parent Company Only Disclosure [Text Block]

Schedule I

Condensed Financial Information of Registrant

(Parent Company Only)

UnitedHealth Group

Condensed Balance Sheets

(in millions, except per share data)	December 31, 2018			December 31, 2017
Assets
Current assets:
Cash and cash equivalents	$	434		$	359
Other current assets	197			575
Total current assets	631			934
Equity in net assets of subsidiaries	83,244			76,231
Long-term notes receivable from subsidiaries	4,461			4,278
Other assets	972			839
Total assets	$	89,308		$	82,282
Liabilities and shareholders’ equity
Current liabilities:
Accounts payable and accrued liabilities	$	618		$	502
Current portion of notes payable to subsidiaries	714			466
Commercial paper and current maturities of long-term debt	1,744			2,749
Total current liabilities	3,076			3,717
Long-term debt, less current maturities	33,490			28,318
Long-term notes payable to subsidiaries	560			1,518
Other liabilities	486			953
Total liabilities	37,612			34,506
Commitments and contingencies (Note 4)
Shareholders’ equity:
Preferred stock, $0.001 par value -10 shares authorized; no shares issued or outstanding	—			—
Common stock, $0.01 par value - 3,000 shares authorized; 960 and 969 issued and outstanding	10			10
Additional paid-in capital	—			1,703
Retained earnings	55,846			48,730
Accumulated other comprehensive loss	(4,160		)	(2,667		)
Total UnitedHealth Group shareholders’ equity	51,696			47,776
Total liabilities and shareholders’ equity	$	89,308		$	82,282

See Notes to the Condensed Financial Statements of Registrant

Schedule I

Condensed Financial Information of Registrant

(Parent Company Only)

UnitedHealth Group

Condensed Statements of Comprehensive Income

	For the Years Ended December 31,
(in millions)	2018			2017			2016
Revenues:
Investment and other income	$	194		$	527		$	522
Total revenues	194			527			522
Operating costs:
Operating costs	35			—			(22		)
Interest expense	1,285			1,114			995
Total operating costs	1,320			1,114			973
Loss before income taxes	(1,126		)	(587		)	(451		)
Benefit for income taxes	251			214			165
Loss of parent company	(875		)	(373		)	(286		)
Equity in undistributed income of subsidiaries	12,861			10,931			7,303
Net earnings	11,986			10,558			7,017
Other comprehensive (loss) income	(1,517		)	14			653
Comprehensive income	$	10,469		$	10,572		$	7,670

See Notes to the Condensed Financial Statements of Registrant

Schedule I

Condensed Financial Information of Registrant

(Parent Company Only)

UnitedHealth Group

Condensed Statements of Cash Flows

	For the Years Ended December 31,
(in millions)	2018			2017			2016
Operating activities
Cash flows from operating activities	$	6,099		$	2,021		$	4,294
Investing activities
Issuances of notes to subsidiaries	(1,420		)	—			(824		)
Repayments of notes to subsidiaries	1,419			2,071			—
Cash paid for acquisitions	(4,066		)	(2,313		)	(2,292		)
Return of capital to parent company	4,196			3,375			2,143
Capital contributions to subsidiaries	(1,259		)	(959		)	(765		)
Other, net	4			—			168
Cash flows (used for) from investing activities	(1,126		)	2,174			(1,570		)
Financing activities
Common stock repurchases	(4,500		)	(1,500		)	(1,280		)
Proceeds from common stock issuances	838			688			429
Cash dividends paid	(3,320		)	(2,773		)	(2,261		)
Repayments of commercial paper, net	(201		)	(3,508		)	(382		)
Proceeds from issuance of long-term debt	6,935			5,291			3,968
Repayments of long-term debt	(2,600		)	(3,472		)	(2,596		)
(Repayments) proceeds of notes from subsidiary	(1,127		)	1,704			(30		)
Other, net	(923		)	(446		)	(421		)
Cash flows used for financing activities	(4,898		)	(4,016		)	(2,573		)
Increase in cash and cash equivalents	75			179			151
Cash and cash equivalents, beginning of period	359			180			29
Cash and cash equivalents, end of period	$	434		$	359		$	180
Supplemental cash flow disclosures
Cash paid for interest	$	1,294		$	1,062		$	974
Cash paid for income taxes	2,379			3,455			4,557
Supplemental schedule of non-cash investing activities
Common stock issued for acquisitions	$	—		$	2,164		$	—
Conversion of note receivable from subsidiaries to equity	—			4,378			—

See Notes to the Condensed Financial Statements of Registrant

Schedule I

Condensed Financial Information of Registrant

(Parent Company Only)

UnitedHealth Group

Notes to Condensed Financial Statements

1.    Basis of Presentation

UnitedHealth Group’s parent company financial information has been derived from its consolidated financial statements and should be read in conjunction with the consolidated financial statements included in this Form 10-K. The accounting policies for the registrant are the same as those described in Note 2 of Notes to the Consolidated Financial Statements included in Part II, Item 8, “Financial Statements and Supplementary Data.”

2.    Subsidiary Transactions

Investment in Subsidiaries. UnitedHealth Group’s investment in subsidiaries is stated at cost plus equity in undistributed earnings of subsidiaries.

Dividends and Capital Distributions. Cash dividends received from subsidiaries and included in Cash Flows from Operating Activities in the Condensed Statements of Cash Flows were $5.6 billion, $3.4 billion and $3.7 billion in 2018, 2017 and 2016, respectively. Additionally, $4.2 billion, $3.4 billion and $2.1 billion in cash were received as a return of capital to the parent company during 2018, 2017 and 2016, respectively.

3.    Commercial Paper and Long-Term Debt

Discussion of commercial paper and long-term debt can be found in Note 8 of Notes to the Consolidated Financial Statements included in Part II, Item 8, “Financial Statements and Supplementary Data.” Long-term debt obligations of the parent company do not include other financing obligations at subsidiaries that totaled $1.3 billion and $625 million at December 31, 2018 and 2017, respectively.

Maturities of commercial paper and long-term debt for the years ending December 31 are as follows:

(in millions)
2019	$	1,750
2020	3,150
2021	3,150
2022	3,015
2023	2,125
Thereafter	22,477

4. Commitments and Contingencies

For a summary of commitments and contingencies, see Note 12 of Notes to the Consolidated Financial Statements included in Part II, Item 8, “Financial Statements and Supplementary Data.”